News | August 25, 2010

TCT Offers PFO Summit, Nurse, Tech Symposium

August 25, 2010 – There will be special tracks available for nurses and technologists and for the transcatheter treatment of patent foramen ovale (PFO) during the Transcatheter Cardiovascular Therapeutics (TCT) meeting Sept. 21-25, 2010, in Washington, D.C.

TCT for Nurses and Technologists

The 19th Annual Cardiovascular Nurse and Technologist Symposium is being expanded this year to one and a half days. The extended track will better provide a forum for discussion of the latest advances in interventional, pharmacologic, structural heart and endovascular strategies for the management of the cardiovascular patient. Content is presented utilizing didactic lectures, case presentations, panel discussions, hands-on cadaver heart workshops and breakout sessions.

New PFO Summit

Co-organized by the PFO Research Foundation and the Cardiovascular Research Foundation (CFR), this pre-TCT gathering is designed for physicians, industry, research sponsors, regulators and patient advocates. It will allow an exchange of knowledge and develop initiatives in research, education, definition of care standards and patient registries. Experts with diverse perspectives in PFO science will offer a day of presentations, panel discussions, debates and working groups. This is not a passive continuing medical education meeting, but rather a summit for action to advance patient care. The PFO Summit will take place Monday, Sept. 20, from 9 a.m. to 6 p.m. in the Walter E. Washington Convention Center.

For more information: www.tctconference.com

Related Content

Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab | November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab | November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Overlay Init